Benjamin P. Saylor
Saylor is content managing editor for Urology Times.
ABU certification/recertification by the numbers – slideshow
This slideshow breaks down data on American Board of Urology certification and recertification among respondents of the 2014 Urology Times State of the Specialty survey.
Product Preview: Agreement reached for phase III clinical trial of bladder Ca agent
In this installment of "Product Preview," also look for information on products in the pipeline for renal cell carcinoma and interstitial cystitis.
Best of AUA 2015: PCa surveillance, surgical controversies create buzz
Urology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas—an information-packed, condensed summary of the top papers and presentations.
AUA issues recommendations on PSA, PCa imaging, mesh
Antimicrobial prescription, imaging for localized prostate cancer, and shared decision making for PSA screening are among the topics of the AUA’s latest Choosing Wisely recommendations.
Urology Times names three to Editorial Council
Urology Times has appointed three expert urologists to its Editorial Council.
Here's who topped Twitter at AUA 2015
This slideshow roundup includes some of the most prominent Twitter participants from AUA 2015 (along with a sampling of their tweets).
Post-RP radiation therapy on decline in U.S.
Post-radical prostatectomy radiation therapy in patients at risk of prostate cancer recurrence is on the wane in the U.S., despite evidence and guidelines supporting the practice, recently published research indicates.
State of Urology: Our experts' top picks for AUA 2015
To help you maximize your AUA experience, Urology Times’ editorial board and other thought leaders have pored over hundreds of abstracts to identify the key trends and can’t-miss research from this year’s meeting.
Genetic variations linked to increased PCa risk identified
The findings could help clinicians differentiate between slow-growing and aggressive tumors
Product offers benefit to PCa patients undergoing RT
The FDA has granted clearance to a hydrogel spacer for prostate cancer patients undergoing radiotherapy.